phase readout
saveNCT07012798: FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC)
view source ↗
comments(0)
5-min edit window · permanent after that